Predictors of Weight Loss Success in Overweight Breast Cancer Survivors

超重乳腺癌幸存者减肥成功的预测因素

基本信息

项目摘要

PROJECT SUMMARY (See instructions): Overweight and inactive breast cancer survivors are at higher risk of cancer recurrence and mortality. Research suggests that losing weight and increasing activity may improve outcomes. As a result, the American Cancer Society has called for weight loss and exercise programs to be standard of care. Behaviorally based weight loss interventions have been under-utilized with breast cancer survivors and no studies have evaluated the predictors of weight loss success. Executive functions are the most common cognitive impairment in breast cancer survivors and may impact their ability to make lifestyle change. Executive functions are the top down control of behaviors and cognition and are an emerging predictor of health-related behaviors. Cancer treatment-related symptoms such as fatigue, also make behavior change a challenge. Our Primary Aim is to determine the degree to which executive functions, as measured by task performance and fMRI, account for the variance in breast cancer survivor's weight loss success. We will also determine the relationship between other cancer treatment-related symptoms, such as fatigue, and intervention success. A behavioral weight loss intervention will be provided to survivors after completing initial cancer therapy. Initial treatment (6 months) will focus on weight loss and increasing exercise. The second 6 months is a maintenance phase with reduced interaction with the interventionist. Predictors of weight loss success (executive functions, fatigue and psychological distress) will be measured at baseline, immediately post intervention (6 months), and after the 6 month maintenance phase (12 months). Executive functions will be assessed using a comprehensive battery of assessments. fMRI will be obtained concurrent with executive function testing at baseline. The impact of executive functions and other treatment-related factors on weight loss success will be determined with regression modeling to explain variability. An important step in the development of efficacious interventions is to better understand the determinants of weight loss and exercise success in overweight BC survivors. Knowledge gained from the proposed project will be used to tailor interventions for survivors that maximize weight loss and exercise.
项目总结(见说明): 超重和不活跃的乳腺癌幸存者癌症复发和死亡的风险更高。 研究表明,减肥和增加运动量可能会改善结果。因此,美国癌症协会呼吁将减肥和锻炼计划作为护理的标准。 在乳腺癌幸存者中,基于行为的减肥干预措施一直没有得到充分利用,也没有研究评估减肥成功的预测因素。执行功能是乳腺癌幸存者最常见的认知障碍,可能会影响他们改变生活方式的能力。 执行功能是对行为和认知的自上而下的控制,是健康相关行为的新兴预测因子。与癌症治疗相关的症状,如疲劳,也使行为改变成为一项挑战。我们的主要目标是确定执行功能在多大程度上解释了乳腺癌幸存者减肥成功的差异,这在多大程度上是通过任务绩效和功能磁共振来衡量的。我们还将确定其他癌症治疗相关症状,如疲倦,与干预成功之间的关系。在完成最初的癌症治疗后,将为幸存者提供行为减肥干预。最初的治疗(6个月)将集中在减肥和增加锻炼上。第二个6个月是维护阶段,与干预者的互动减少。减肥成功的预测因素(执行功能、疲劳和心理困扰)将在基线、干预后立即(6个月)和6个月维持阶段(12个月)后进行测量。将使用一系列综合评估对行政职能进行评估。功能磁共振成像将在基线时与执行功能测试同时进行。执行功能和其他与治疗相关的因素对减肥成功的影响将通过回归模型来确定,以解释变异性。开发有效干预措施的一个重要步骤是更好地了解超重BC幸存者减肥和运动成功的决定因素。从拟议项目中获得的知识将用于为幸存者量身定做干预措施,以最大限度地减轻体重和锻炼。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Kim Dittus其他文献

Kim Dittus的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Kim Dittus', 18)}}的其他基金

EFFECT OF ADJUVANT CHEMO FOR EARLY BREAST CA ON BRAIN IMAGING AMP; COGNITION
早期乳腺癌辅助化疗对脑成像放大器的影响;
  • 批准号:
    8166994
  • 财政年份:
    2010
  • 资助金额:
    $ 30.95万
  • 项目类别:
OUTCOMES OF ONCOLOGY THERAPY IN THE ELDERLY: FUNCTIONAL DECLINE
老年人肿瘤治疗的结果:功能衰退
  • 批准号:
    8166993
  • 财政年份:
    2010
  • 资助金额:
    $ 30.95万
  • 项目类别:
PHYSICAL FUNCTION & BODY COMP DURING & AFTER TRT FOR HEMATOLOGIC MALIGNANCY
物理功能
  • 批准号:
    7952120
  • 财政年份:
    2009
  • 资助金额:
    $ 30.95万
  • 项目类别:
Predictors of Weight Loss Success in Overweight Breast Cancer Survivors
超重乳腺癌幸存者减肥成功的预测因素
  • 批准号:
    8465592
  • 财政年份:
  • 资助金额:
    $ 30.95万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 30.95万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 30.95万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 30.95万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 30.95万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 30.95万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 30.95万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 30.95万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 30.95万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 30.95万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 30.95万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了